gvtcx

Supply agreement SARS-CoV-2 mRNA Vaccine

Business Energy and Industrial Strategy Published 19 May 2021 Contracts Finder

key details

Value£1
Statuscomplete
Category (CPV) 33651600
Deadline16 Nov 2020
Contract start23 Nov 2020
Contract end31 Dec 2021
Proceduredirect
SME suitableNo
OCIDocds-b5fd17-7ae92ed0-6b1c-4a11-8c31-d66463e3803a

Awards (2)

This procurement was awarded to 1 suppliers. Values shown are per-award; the notice total is £1.

SupplierValueDateStatus
Moderna Switzerland GmbH £1 16 Nov 2020 active
Moderna Switzerland GmbH · · active

description

The procurement of the mRNA-1273 vaccine.

notice history

5 notices published against this procurement.

PublishedTypeRegimeNotice
19 May 2021 Award update (awardUpdate) · a3df05e8-9916-4c12-90c3-0c28611cf48e-437314
20 May 2021 Contract award notice (F03) Earlier regulations 011244-2021
20 May 2021 Award (award) · b2d73286-4939-4120-b1fd-bf44d559b4e0-437894
5 May 2022 Award update (awardUpdate) · 8930d6c5-354d-44d0-8540-c134fe59aa0a-535052
26 Oct 2022 Contract award notice (F03) Earlier regulations 030205-2022

more from Business Energy and Industrial Strategy

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.